RS Crum Inc’s iShares Biotechnology ETF IBB Stock Holding History

RS Crum Inc’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.6M	Hold	9,451	–	–	0.31%	33
2025 Q4	$1.6M	Hold	9,451	–	–	0.32%	30
2025 Q3	$1.36M	Hold	9,451	–	–	0.3%	32
2025 Q2	$1.2M	Hold	9,451	–	–	0.29%	32
2025 Q1	$1.21M	Sell	9,451 -205	-2%	-$27.8K	0.33%	31
2024 Q4	$1.28M	Hold	9,656	–	–	0.32%	32
2024 Q3	$1.41M	Sell	9,656 -127	-1%	-$18.4K	0.33%	31
2024 Q2	$1.34M	Hold	9,783	–	–	0.35%	31
2024 Q1	$1.34M	Sell	9,783 -145	-1%	-$19.8K	0.37%	30
2023 Q4	$1.35M	Sell	9,928 -160	-2%	-$19.5K	0.42%	30
2023 Q3	$1.23M	Hold	10,088	–	–	0.44%	32
2023 Q2	$1.28M	Sell	10,088 -21	-0.2%	-$2.73K	0.46%	33
2023 Q1	$1.31M	Hold	10,109	–	–	0.5%	31
2022 Q4	$1.33M	Sell	10,109 -2,965	-23%	-$383K	0.62%	30
2022 Q3	$1.53M	Hold	13,074	–	–	0.8%	21
2022 Q2	$1.54M	Hold	13,074	–	–	0.79%	22
2022 Q1	$1.7M	Sell	13,074 -288	-2%	-$37.5K	0.96%	20
2021 Q4	$2.04M	Buy	+13,362	New	+$2.07M	1.13%	18

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

RS Crum Inc's IBB Position: Q1 2026 in Review

RS Crum Inc held its iShares Biotechnology ETF (IBB) position steady in Q1 2026 at 9,451 shares worth $1.6M. The position accounts for 0.31% of the portfolio, ranked #33.

RS Crum Inc first reported a position in IBB in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.04M in Q4 2021. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

RS Crum Inc held 9,451 shares of iShares Biotechnology ETF worth $1.6M as of Q1 2026.
RS Crum Inc left its iShares Biotechnology ETF share count unchanged in Q1 2026.
iShares Biotechnology ETF made up 0.31% of RS Crum Inc's portfolio in Q1 2026, its #33 holding.
RS Crum Inc first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 18 quarters since.
RS Crum Inc's iShares Biotechnology ETF position peaked at $2.04M in Q4 2021.
917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on RS Crum Inc's 13F filing for Q1 2026, filed 15 Apr 2026.